Global Wheelchairs Industry Gears Up for Steady Growth at 3.2% CAGR, Reaching US$7.9 Billion by 2032 | FMI Study

Global Wheelchairs Industry
Global Wheelchairs Industry

The Global Wheelchairs Industry is poised for sustained expansion, driven by the rising needs of an aging population and the increasing demand for accessible mobility solutions. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to reach a significant valuation of US$7.9 billion by 2032. This translates to a steady Compound Annual Growth Rate (CAGR) of 3.2% over the next decade. In 2022, the market value stood at US$5.7 billion, reflecting the crucial role wheelchairs play in ensuring mobility and independence for individuals with disabilities.

In a time when accessibility and innovation coexist, FMI’s extensive analysis highlights the critical role that cooperation between the public, commercial, and nonprofit sectors plays. It is believed that utilizing the combined knowledge and assets of these industries will promote innovation and eventually remove barriers to the accessibility and cost of assistive technology (AT).

Request a Sample of this Report Using a Work Email to Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15754

A wheelchair is considered appropriate if it: satisfies the user’s demands and environmental requirements; offers a proper fit with ergonomic adjustment; is safe and reliable; is readily available in the nation; and can be obtained, maintained, and provided with services in the nation at a reasonable price. The usage of an appropriate wheelchair improves users’ mobility and flexibility, which is a requirement for active involvement in civic, professional, and educational activities.

Wheelchairs are among the most widely used assistive devices. Those who require wheelchairs have mobility limits and may include individuals with congenital abnormality, people with developmental and neurological problems (such as cerebral palsy or muscular dystrophy), people with a spinal cord injury, and people with musculoskeletal conditions (lower limb amputation), people living with physical handicap caused by polio or non-communicable diseases (NCDs) such as diabetes or stroke, and older people.

The wheelchair market is expected to grow as demand is created and consolidated around the best products in terms of effectiveness, features, quality, and cost. Additionally, to lower production costs and promote the adoption of strict quality standards, manufacturers and suppliers must collaborate to shape the Global Wheelchairs Industry for greater revenue sales.

Key Takeaways from Global Wheelchairs Industry Study

  • Manual wheelchairs are the leading segment as a product, and hold approximately 5% market share in 2021, owing to their adoption by people with mobility issues, who do not suffer from chronic conditions.
  • The lightweight wheelchair segment is set to lead in terms of function for wheelchairs with a projected market share of around 0% by 2032, owing to the ease of its use.
  • Institutional sales accounted for around 2% of the Global Wheelchairs Industry, by distribution channel, in 2021, owing to the high adoption of treatment within institutional settings.
  • North America is considered the leading region with a global share of 4% in 2021, owed to the large number of available distributors for wheelchairs in the region.

“Mobility issues associated with ageing are likely to affect older generations, which is predicted to raise demand for wheelchairs and fuel market expansion for wheelchairs over the forecast period,” says an analyst of Future Market Insights.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15754

Global Wheelchairs Industry Competition

The market for wheelchairs is highly fragmented, and there exist several competitors within the market sphere. Several local producers exist in low and middle-income nations, owing to favorable government regulations, incentives to manufacture locally, and the belief that wheelchairs are a low-tech product.

  • Invacare Corporation announced the release of a new, slimmer version of the Invacare® AVIVA® STORM RXTM rear-wheel drive power wheelchair in January 2022.
  • Sunrise Medical announced the introduction of two new electric wheelchairs in January 2022 for both its adult QUICKIE and pediatric ZIPPIE lines.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the wheelchairs market in its latest study, presenting a historical demand assessment of 2015 – 2021 and projections for 2022 – 2032. The Global Wheelchairs Industry is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The research study is based on the product – (Manual Wheelchairs, and Powered Wheelchairs), function (standard transport wheelchairs, self-propelled wheelchairs, sports wheelchairs, standing wheelchairs, recliners wheelchairs, bariatric wheelchairs, and lightweight wheelchairs), and distribution channel (institutional sales, and retail sales), across seven key regions of the world.

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-15754

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Freeze Drying Market to Reach USD 1,262.78 Million in 2024, Projected to Grow at 8.6% CAGR to USD 2,881.55 Million by 2034

Freeze Drying
Global Freeze Drying Market

The global Freeze Drying market is poised for significant growth, with a forecasted compound annual growth rate (CAGR) of 8.6% from 2024 to 2034. The market is expected to achieve a valuation of USD 1,262.78 million in 2024 and is projected to reach USD 2,881.55 million by 2034.

This robust market expansion is driven by the growing food processing and pharmaceutical industries. As awareness of the benefits of freeze drying continues to increase, demand is expected to rise significantly. Freeze drying offers enhanced desiccant drying and air-drying efficiency, making it a preferred method in various applications.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15758

Market expansion is being propelled by the expanding pharmaceutical and food processing sectors. The benefits of the product, such as improved desiccant drying and air-drying effectiveness, should enhance demand for freeze drying.

Key Takeaways:

  • The global freeze drying market is estimated at US$1.26 billion in 2024 and is projected to reach US$2.88 billion by 2034, growing at a robust CAGR of 8.6%.
  • The expanding food processing and pharmaceutical industries are key drivers of market growth.
  • Rising awareness of freeze drying’s advantages, such as superior drying efficiency and product preservation, is fueling demand.

Competitive Analysis

The market for food freeze-drying machines has a competitive landscape with multiple freeze-drying manufacturers driving innovation and technological advancement. Leading providers of freeze drying exhibit creativity and innovation in a variety of technologies. Azbil Corporation, Zirbus Technology GmbH, and HOF Sonderanlagenbau GmbH all exhibit dependability and creative problem-solving.

The unique advantages of Cryotec.Fr, MechaTech Systems Ltd., and Millrock Technology, Inc. improve the competitive environment and drive the development of freeze-drying technology. Cuddon Freeze Dry, Martin Christ Gefriertrocknungsanlagen GmbH, and SP Industries, Inc. have a significant impact on the freeze drying market dynamics with their state-of-the-art lyophilized goods.

Pivotal Freeze Drying Providers:

  • Azbil Corporation
  • Zirbus Technology GmbH
  • HOF Sonderanlagenbau GmbH
  • Millrock Technology, Inc.
  • Cryotec.Fr
  • MechaTech Systems Ltd.
  • SP Industries, Inc.
  • Martin Christ Gefriertrocknungsanlagen GmbH
  • Cuddon Freeze Dry
  • Neologic Engineers Private Limited
  • Labconco Corporation
  • BÜCHI Labortechnik AG
  • Yamato Scientific America Inc.
  • Freeze Drying Systems Ltd.
  • Freeze Drying Systems Pvt. Ltd.
  • IMA – Industria Macchine Automatiche S.p.A.
  • GEA Group

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15758

Key Segments

By Product:

  • Dryer
    • Tray-style dryers
    • Rotary Freeze Dryers
    • Manifold Freeze Dryers
  • Accessories
    • Drying Chamber
    • Vacuum System
    • CIP (Clean-in-place) Systems
    • Other Accessories

By Scale of Operations:

  • Pilot-scale
  • Laboratory-scale
  • Industrial-scale

By Distribution Channel:

  • Biopharmaceutical Companies
  • Food and Beverage Companies
  • Academic and Research Institutes
  • CRO and CMO
  • Hospitals
  • Research Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Dive Into Comprehensive Market Insights: Purchase Now to Access:
 https://www.futuremarketinsights.com/checkout/15758

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Regenerative Artificial Skin Industry Set for Rapid Growth at 9.9% CAGR, Reaching US$5.6 Billion by 2032 | FMI Analysis

Global Regenerative Artificial Skin Industry
Global Regenerative Artificial Skin Industry

The Global Regenerative Artificial Skin Industry is on the cusp of a significant expansion, driven by the increasing need for advanced wound care solutions. According to market projections, the industry is expected to reach a staggering US$5.6 billion by 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of 9.9% over the forecast period. This impressive growth is fueled by the rising demand for innovative wound management options in hospitals and clinics worldwide.

Global Regenerative Artificial Skin Industry: Overview

The Global Regenerative Artificial Skin Industry is undergoing changes due to burn management reforms in several nations like the United States, the United Kingdom, and Australia. Furthermore, several companies in the marketplace increasing their product portfolio in the regenerative artificial skin market may change the market dynamics over a given period of forecast.

By material type, sub-segments such as engineered skin material in the Global Regenerative Artificial Skin Industry are expected to grow in positive traction owing to its immediate capability of composite skin material and success rate in artificial skin regeneration.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2065

According to The American Burn Association estimated that in 2015, 486,000 population received medical treatment for minor burns, and 70,000 populations were hospitalized for severe skin burns for acute care.

Skin is the biggest organ in the body also it is one of the most important organs in the body. Skin acts as a barrier between the outside environment and the inside body environment. Skin helps to maintain moisture levels in the body. Skin is responsible for the temperature regulation in the body through sweating. The skin protects the body by keeping harmful bacteria outside the body. Skin has many nerve ends, which help to respond to heat, pressure, touch, cold, and pain. Skin helps to synthesize Vitamin D, which is required for normal bone and teeth growth. The skin has a two-layer epidermal layer and a dermal layer.

The epidermal layer is the outer layer that acts as the body’s major barrier against uncertain conditions. The dermal layer is the layer of skin between the epidermal and the subcutaneous tissues. Accidental skin burns are increasing day by day. Life-threatening skin injuries, traumas, and burns require immediate surgical procedures to restore skin and avoid future complications. Skin burns may be due to heat, fire, radiation, or chemicals. Skin burns are of three levels i.e. 1st, 2nd, and 3rd degree burns.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-2065

Global Regenerative Artificial Skin Industry: Drivers and Restraints

The regenerative artificial skin market is expected to rise owing to the rising incidence of burns and increased accidents involving fire. Apart from this, increased skin diseases, harmful acid accidents, and major body surgeries positively impact the Global Regenerative Artificial Skin Industry over the forecast period. However regulatory approval of regenerative artificial skin acts as a hamper to the growth of the market. Also acceptance by the body, sterile products, and nutritional supply to regain the natural structure hamper the growth of the Global Regenerative Artificial Skin Industry.

Regenerative Artificial Skin Industry: Region-wise Outlook

Geographically, the Global Regenerative Artificial Skin Industry is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for regenerative artificial skin market due to deeper market penetration of the procedures and the strong presence of big players in the market. Asia Pacific is anticipated to register positive growth owing to increased cosmetic surgeries and rising incidence of accidental burns.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/2065

Global Regenerative Artificial Skin Industry: Key Players

  • Integra Life Sciences Corporation
  • Mylan N.V.
  • Johnson & Johnson Services, Inc.
  • Smith & Nephew
  • Mallinckrodt Plc.
  • Molnlycke Health Care AB
  • 3M
  • Medtronic Plc.
  • Mimedx Group
  • Baxter Corporation

Key Segments Covered in the Global Regenerative Artificial Skin Industry Analysis

by Material Type:

  • Temporary Skin Material
  • Single Layer Material
  • Bi-layered Material
  • Permanent Skin Material
  • Epidermal Skin Material
  • Dermal Skin Material
  • Composite Skin Material
  • Skin graft
  • Allograft
  • Xenograft
  • Engineered Skin Material

by End User:

  • Hospitals
  • Clinics
  • Burn Care Centers

by Region:

  • North America Regenerative Artificial Skin Market
  • Latin America Regenerative Artificial Skin Market
  • Europe Regenerative Artificial Skin Market
  • East Asia Regenerative Artificial Skin Market
  • South Asia Regenerative Artificial Skin Market
  • Oceania Regenerative Artificial Skin Market
  • Middle East & Africa Regenerative Artificial Skin Market

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug Formulation Market to Reach USD 1.58 Trillion by 2022, Expected to Grow at a 5.6% CAGR Through 2032

Drug Formulation
Global Drug Formulation Market

The global Drug Formulation market is projected to experience steady growth, with demand increasing at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2032. According to recent market analysis, the market valuation is estimated to reach an impressive USD 1.58 trillion by 2022.

A significant driver of this growth is the exponential rise in oral drug formulations, which are expected to grow at a CAGR of 6.0% during the forecast period. The increasing preference for oral formulations is attributed to their convenience, ease of administration, and improved patient compliance.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15755

Because it makes it easier to convert active pharmaceutical ingredients (APIs) into completed medications that are safe for people to take, the global drug formulation market is essential to the pharmaceutical sector. Both the rising demand for pharmaceutical products and improvements in the technology of medicine formulation account for the anticipated growth.

Key Takeaways:

  • The global drug formulation market is expected to reach US$2.87 trillion by 2032, growing at a CAGR of 5.6%.
  • Oral formulations are projected to experience the fastest growth, with a CAGR of 6.0% during the forecast period.
  • Rising demand for innovative drug delivery systems and growing healthcare needs worldwide are key drivers.

Competitive Landscape:

In the medication formulation industry, major players are employing methods such as advanced product launches through approvals and mergers and acquisitions. The major businesses are concentrating on working with the research institutes to gain a competitive edge in the marketplace.

  • A definitive merger agreement between Bristol Myers Squibb and Turning Point Therapeutics was signed on June 20, 2022. This acquisition will expand BMS’s selection of oncology drugs because Turning Point Therapeutics is a precision oncology company that is still in the clinical development stage.
  • AstraZeneca introduced The Evusheld long-acting antibody combo to the public on March 20, 2022. For the pre-exposure prophylaxis (prevention) of COVID-19 in a sizable population, it has received authorization in Europe.

Key Companies Profiled:

  • AstraZeneca plc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • 3M Company
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Sanofi SA
  • GlaxoSmithKline plc
  • Boston Scientific Corporation
  • Gerresheimer AG
  • Nimbus Therapeutics
  • Antares Pharma, Inc.
  • IDEAYA Biosciences, Inc.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15755

Key Market Segments Covered in Drug Formulation Industry Research:

By Dosage Form:

  • Oral formulations
    • Tablets
      • Immediate Release
      • Modified Release
      • Chewable
      • Effervescent
    • Capsules
      • Hard Gelatin Capsules
      • Softgel Capsules
      • Others
    • Powders & Granules
    • Lozenges & Pastilles
    • Gummies
    • Others
  • Parenteral formulations
    • Solutions
    • Suspensions
    • Emulsions for injection or infusion
    • Powders for injection or infusion
    • Gels for injection implants
  • Topical formulations
    • Pastes
    • Ointments and oils
    • Creams, lotions, and foams.
    • Gels, tinctures, and powders
    • Sprays and patches
  • Inhalation formulations
    • Pressurized Metered Dose Inhaler
    • Dry Powder Inhaler (DPI)
    • Nebulizer

By Indication:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Gastrointestinal Diseases
  • Musculoskeletal Disorders
  • Dermatological Disorders
  • Other

By End User:

  • Big pharma
  • Small & Medium Size Pharma
  • Biotech Companies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Get Full Market Analysis Now: Purchase The Report:
https://www.futuremarketinsights.com/checkout/15755

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Synthetic Biology Market to Skyrocket from USD 3.75 Billion in 2024 to USDF 31.73 Billion by 2034, Boasting a 23.8% CAGR

Synthetic Biology
Global Synthetic Biology Market

The global Synthetic Biology market is set for exponential growth, with an expected increase from USD 3.75 billion in 2024 to a staggering USD 31.73 billion by 2034. This impressive expansion corresponds to a compound annual growth rate (CAGR) of 23.8% over the forecast period.

The surge in the synthetic biology market is driven by the rising need to enhance practical capabilities, redesign naturally occurring systems, and develop new biological components, tools, and systems. These advancements are paving the way for innovative applications across various industries, including healthcare, agriculture, and environmental management.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1226

Its rapid expansion is being driven by the revolution that synthetic biology is bringing to numerous businesses and tackling pressing global concerns. The market is driven by its ability to revolutionize industries and provide cutting-edge answers to urgent problems.

Key Takeaways:

  • The synthetic biology market is projected to surge from US$3.75 billion in 2024 to US$31.73 billion by 2034, reflecting a remarkable CAGR of 23.8%.
  • Rising demand for enhanced functionalities, redesigned natural systems, and novel biological tools are fueling market growth.
  • Synthetic biology holds immense potential in addressing critical challenges related to bio-based chemicals, renewable fuels, and affordable medications.
  • The need for genetically modified crops to ensure global food security is further propelling advancements in the field.
  • The convergence of technological breakthroughs and growing market needs positions synthetic biology as a key solution provider for social and environmental concerns, fostering further innovation in the coming years.

Demand for sustainable solutions: Businesses and consumers alike are looking for more environmentally friendly options. The field of synthetic biology has promise for the development of bio-based compounds, renewable fuels, and more reasonably priced pharmaceuticals and vaccinations. Synthetic biology solutions are becoming increasingly in demand as a result of this move towards sustainable practices.
Concerns about food security: To maintain food security in the face of an increasing global population, creative solutions are required. Developments in synthetic biology are essential to the creation of genetically engineered crops with increased resistance and yields. The potential for this technology to alleviate the world’s food shortages is enormous.

Recent Developments in the Synthetic Biology Industry

  • In January 2024, Rice University established the Rice Synthetic Biology Institute (RSBI) in Texas to promote collaborative research in synthetic biology and convert it into beneficial technologies. The institute aims to attract global attention to Rice’s esteemed synthetic biology program and retain top talent.
  • In January 2024, Kerstin Göpfrich founded a research group at the Max Planck Institute for Medical Research in Heidelberg, Germany. The group focuses on engineering life and exploring new cell abilities to create new life forms.
  • In November 2023, the United Kingdom-based team led by Ben Blount at the University of Nottingham developed a yeast strain with over 50% synthetic DNA, a significant achievement in the Saccharomyces cerevisiae (Sc) 2.0 project, a global effort to produce synthetic versions of the yeast genome.
  • In July 2023, WPI researchers Eric Young and Kevin Keating developed a method to express genes across bacterial species by designing a generalized collection of DNA parts that can be used with multiple species to assemble DNA sequences.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-1226

Key Companies in the Synthetic Biology Market:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Novozymes
  • Agilent Technologies, Inc.
  • Codexis, Inc.
  • Bota Biosciences Inc.
  • Creative Biogene.
  • Creative Enzymes.
  • Enbiotix, Inc.
  • Illumina, Inc.
  • Eurofins Scientific
  • New England Biolabs
  • Pareto Bio, Inc.
  • Scarab Genomics, Llc
  • Synthego
  • Twist Bioscience
  • Synthetic Genomics Inc.
  • BioBricks Foundation
  • DIYbio
  • Amyris
  • Cyrus Biotechnology
  • TeselaGen

Key Segments:

By Product:

  • Oligonucleotides
  • Enzymes
  • Synthetic Cells
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism

By Application:

  • Healthcare
  • Non-Healthcare

By End User:

  • Biopharmaceutical manufacturers
  • Academic and Government Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Act Now for Thorough Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/1226

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Softgel Capsules Industry Poised for Steady Growth at 6.0% CAGR, Reaching US$1.9 Billion by 2032 | FMI Study

Global Softgel Capsules Industry
Global Softgel Capsules Industry

The future of the Global Softgel Capsules Industry is brimming with promise, fueled by their versatility and growing demand for convenient and effective drug delivery solutions. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to reach a significant valuation of US$1.9 billion by 2032. This translates to a steady Compound Annual Growth Rate (CAGR) of 6.0% over the next decade, reflecting a substantial rise from the estimated US$1.1 billion market value at the end of 2022.

The driving force behind this unprecedented growth is the escalating interest in the oral delivery of medications with low water solubility. The development of Soft Gelatin Capsules (SGCs) delivery systems has gained substantial traction, offering a promising solution to the challenges posed by low-solubility medications in the pharmaceutical pipeline.

Soft Gelatin Capsules provide a sophisticated delivery method, encapsulating drugs and facilitating the transport of active constituents to systemic circulation. This innovative approach addresses formulation constraints, ensuring superior dose accuracy, homogeneity, manufacturing consistency, and product stability.

Request a Sample of this Report Using a Work Email To Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15724

This is crucial for drugs that are susceptible to oxidative and hydrolytic breakdown. The expanding cosmetics industry’s desire for soft gel capsules to supply cosmeceuticals in the form of capsules drives the growth of the worldwide soft gel capsules market.

The rising consumption of supplements in capsule form increases demand for soft gel capsules, propelling the global soft gel capsules market. The pharmaceutical industry’s use of soft gel capsules is also aided by improvements to the capsules’ outer shell and compatibility with the ingredients inside, which have become two of the market’s main growth drivers.

Key Takeaways from Global Softgel Capsules Industry Study

  • Gelatin softgel capsules are the leading segment as a product, and hold approximately 3% market share in 2021, owing to their property of increased bioavailability, and greater absorption.
  • Type-A gelatin (pork skin) segment is set to lead in terms of raw material for softgel capsules with a projected market share of around 5% by 2032, owing to the high availability of porcine sources of raw material globally.
  • By application, health supplements are leading in the Global Softgel Capsules Industry, and are expected to continue to do so with a projected CAGR of 5% during the forecasted years, as they are easy to swallow and disintegrate quickly.
  • By end users, CMOs hold a dominant market share of 2% in the global market in 2021, owing to the lowered cost of production, and higher output.
  • Oral softgels are leading the market as a route of administration, holding a share of around 7% in 2021, owing to higher patient preference.
  • North America is considered the leading region with a global share of 7% in 2021, owed to a large number of available distributors for softgel capsules in the region.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15724

“Rising prevalence of chronic diseases is promoting the adoption of softgel capsules with greater bioavailability, enhanced absorption, and a long shelf-life,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Global Softgel Capsules Industry Market Competition

The market for softgel capsules is fragmented, and there exist several contract manufacturing players within the market sphere. Key players promote market expansion through novel product launch activities along with acquisitions and collaborations.

  • The delayed/enteric release softgel OptiGel® DR by Catalent was introduced in October 2020 for applications in pharmaceutical and nutraceutical applications.
  • Sirio Pharma Company Limited announced in July 2022 that Sirio will purchase 80% of Best Pharmaceuticals, a contract manufacturer of nutraceuticals and dietary supplements.

Global Softgel Capsules Industry Key Companies Profiled

  • Aenova Group GmbH
  • Fuji Capsule Co., Ltd
  • Sirio Pharma Company Limited
  • Catalent, Inc
  • EuroCaps Ltd
  • Guangdong Yichao Biological Co., Ltd.
  • Elnova Pharma
  • Captek Softgel International Inc
  • Hunan Er-Kang Pharmaceutical Co., Ltd
  • Soft Gel Technologies Inc.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/15724

Key Segments Covered in Global Softgel Capsules Industry Research

By Product:

  • Gelatin Softgel Capsules
  • Vegetarian Softgel Capsules

By Raw Material:

  • Type-A Gelatin (Pork Skin)
  • Type-B Gelatin (Animal Bones & Skin)
  • Fish Bone Gelatin
  • Cellulose Derivatives
  • Starch Material

By Application:

  • Antacid & Antiflatulent Preparations
  • Antianemic Preparations Hematinic Preparations)
  • Anti-inflammatory Drugs
  • Antibiotic & Antibacterial Drugs
  • Cough & Cold Preparations
  • Cardiovascular Therapy Drugs
  • Health Supplements
  • Vitamin & Dietary Supplements
  • Other Therapeutic Applications

By End User:

  • In-house Manufacturing
    • Pharmaceutical Companies
    • Nutraceutical Companies
    • Cosmeceutical Companies
  • Contract Manufacturing Organizations

By Route of Administration:

  • Oral Softgels
  • Suppositories
  • Pessaries
  • Twist off Softgels
  • Others

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cardiac Ambulatory Monitoring Industry Poised for Steady Growth at 5.2% CAGR, Reaching US$21.6 Billion by 2032 | FMI Analysis

Global Cardiac Ambulatory Monitoring Industry
Global Cardiac Ambulatory Monitoring Industry

The Global Cardiac Ambulatory Monitoring Industry is on track for a stable and promising expansion, fueled by growing public awareness about heart health. A recent analysis by Future Market Insights (FMI), a leading market research firm, projects a steady Compound Annual Growth Rate (CAGR) of 5.2% for the market over the next decade. This translates to a significant increase, with the market valuation expected to reach US$21.6 billion by 2032, up from an estimated US$13.3 billion in 2021.

The global escalation in cardiac conditions can be attributed to various factors, including rising obesity rates, the prevalence of diabetes mellitus, smoking habits, elevated blood cholesterol levels, hypertension, and increasingly unhealthy lifestyles. These alarming trends are propelling the demand for advanced cardiac ambulatory monitoring devices, thereby creating a substantial market for innovative solutions that cater to the growing healthcare needs of individuals worldwide.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15723

During the projected period, the global market is anticipated to be driven by the steadily rising use of cardiac ambulatory monitoring devices for the treatment of cardiac arrhythmia and other cardiac disorders. Cardiac ambulatory monitors can be used both inside and externally. For instance, implantable loop recorders with a three-year battery life can be placed transdermal. As a result, the electrical activity of the heart is continuously monitored.

Due to the rapid advancement of technology, rising rates of cardiovascular disorders around the world, and an aging population, the market for cardiac ambulatory monitoring is growing at a rapid rate. The market for cardiac ambulatory monitoring devices is anticipated to grow significantly over the next few years as a result of improvements in technology and innovations in cardiac ambulatory monitoring devices.

As cardiac ambulatory monitoring devices are not reaching the customer at their full potential due to associated side effects and the pricey nature of the devices, companies are introducing portable cardiac ambulatory monitoring devices at reasonable costs, and this might significantly improve the usability and adoption of cardiac ambulatory monitoring devices.

Manufacturers releasing products like portable/wearable gadgets with cutting-edge features like Bluetooth connectivity, integral ECG monitors, fitness trackers, and other numerous functions, will help in growing sales of the devices, as a result, the Global Cardiac Ambulatory Monitoring Industry will expand during the forecast period.

“Rising initiatives to promote a healthy lifestyle, as well as the increasing awareness about the cardiac monitoring devices is set to propel the sales of Global Cardiac Ambulatory Monitoring Industry,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15723

Key Takeaways from Global Cardiac Ambulatory Monitoring Industry Study

  • ECG devices are the leading segment as a product and hold approximately 42.2% market share in 2021. Owing to their lower pricing, these devices can also be utilized in medical operations, along with a variety of other cardiac diagnostic tests, telemetry monitoring equipment, and other tools.
  • Hospitals are the leading segment as end users, and held about 35.0% market share in 2021, due to the rising incidence of CVDs, the rising number of hospital visits, and the rising number of cardiac device implantation procedures.
  • By region, North America is leading the Global Cardiac Ambulatory Monitoring Industry and is expected to continue to do so with a projected CAGR of 4.4% during the forecasted years.
  • The region of Europe is slated to be the second dominant segment in terms of growth, holding a market share of around 25.6% in the global cardiac ambulatory monitoring market, in 2021.

Click Here To Purchase Your Full Report
https://www.futuremarketinsights.com/checkout/15723

Global Cardiac Ambulatory Monitoring Industry Competition

Major manufacturers concentrate on a range of strategic goals, including regional growth, product development, and strategic alliances and partnerships. For quick and simple diagnosis, new portable monitoring devices are being introduced for heart activity monitoring.

  • Boston Scientific Corporation stated in January 2021 that it has acquired Preventice Solutions Inc. to provide ambulatory cardiac monitors (including short- and long-term Holter monitors), cardiac event monitors, and MCT.
  • To increase the production of AEDs for cardiac monitoring and provide related services and accessories, ZOLL Medical Corporation announced in August 2019 that it had acquired Cardiac Science Corporation.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Teeth Whitening Market to Reach USD 7,204 Million by 2024, Projected to Grow at a 4.10% CAGR Through 2034 at a 4.10% of CAGR

teeth whitening market
Global teeth whitening market

The global Teeth Whitening market is poised for significant growth, with an estimated market size of USD 7,204 million by 2024. The demand for teeth whitening products is anticipated to rise at a compound annual growth rate (CAGR) of 4.10% over the next decade, reaching a projected valuation of USD 10,766.7 million by 2034.

Companies within the teeth whitening sector are innovating to meet diverse customer needs by offering personalized solutions tailored to individual preferences. These advancements cater to a broad consumer base, including different age groups, ensuring that a wide range of dental requirements are met.

In a time when self-care and wellbeing are essential, individuals are prioritizing dental cleanliness and attractiveness, which is driving up demand for teeth whitening solutions. Customers have many options to choose from, including over-the-counter drugs and professional dental procedures, in order to get a whiter, brighter smile and more confidence.

The worldwide teeth-whitening market is expanding due to the increasing number of customers who are seeking a brighter smile. As consumers place an increasing amount of importance on oral aesthetics, the market for teeth whitening solutions is growing.

Request Your Detailed Report Sample With Your Work Email:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15717

Furthermore, the teeth-whitening industry is purposefully growing to cater to a wider range of consumer segments. This entails targeting different age groups to ensure that there are solutions that suit everyone seeking a whiter smile. This calculated rise accelerates the market’s overall growth by making it possible for more consumers to adopt the teeth-whitening trend.

Key Takeaways:

  • The teeth whitening market is estimated at USD 7.2 billion in 2024 and is projected to reach USD 10.8 billion by 2034, growing at a CAGR of 4.1%.
  • Rising demand for whiter smiles is fueling the market, with manufacturers offering personalized solutions to cater to diverse customer preferences.
  • The industry is expanding to include a wider range of consumer markets, encompassing different age groups.

Competition Outlook of the Teeth Whitening Market:

There are several well-known companies, up-and-coming startups, and private label brands in the teeth-whitening market, all fighting for a spotless grin in customers’ shopping carts. In order for brands to stay ahead of the curve, product innovation is crucial given the steady stream of new technology and components.

This means inventing at-home whitening kits that are easy to use and incorporate innovative application techniques, researching developments in light-based whitening technologies, and formulating effective yet delicate whitening products.

DTC brands are upending the market by providing affordable, individualized teeth-whitening treatments and easy online subscriptions. This compels traditional physical merchants and dentistry offices to alter their product lines and business models.

Recent Developments in the Teeth Whitening Industry

  • Procter & Gamble launched Crest Whitening Emulsions, which is a breakthrough formula that delivers five times more active hydrogen peroxide to the teeth and does not require rinsing or brushing.
  • Colgate Palmolive expanded its Colgate Optic White line of products with offerings such as Colgate Optic White Renewal Toothpaste.
  • Johnson & Johnson launched Listerine Healthy White Vibrant Multi-Action Rinse, which is a mouthwash that whitens teeth, prevents stains, and kills bad breath germs. The company also partnered with Byte, a direct-to-consumer brand that offers at-home teeth aligners and whitening kits, to provide oral care products and education to Byte customers.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-15717

Key Companies in the Market:

  • Procter & Gamble
  • Colgate Palmolive
  • Johnson & Johnson
  • Unilever
  • Ultradent Products Inc.
  • Church & Dwight Co.
  • GlaxoSmithKline Plc
  • 3M Company
  • DENTSPLY international
  • Henkel AG & Co KGaA
  • Institut Straumann AG
  • Ivoclar Vivadent AG

Key Segments:

By Product:

  • Teeth Whitening Gels & Strips
    • Carbamide Peroxide with Potassium Nitrate and Fluoride
    • Carbamide Peroxide
    • Hydrogen Peroxide
  • Teeth Whitening Devices
    • LED Lights
      • Corded LED Lights
      • Cordless LED Lights
    • UV Lights
    • Halogen Lights
  • Oral Care Products
  • Others

By Distribution Channel:

  • Institutional Sales
    • Dental Hospitals
    • Dental Clinics
    • Group Dental Practice
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Hypermarket and Supermarket
    • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Detailed Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15717

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Platelet Function Test Industry Poised for Steady Growth at 6.3% CAGR, Reaching US$2.2 Billion by 2032 | FMI Analysis

Global Platelet Function Test Industry
Global Platelet Function Test Industry

The Global Platelet Function Test Industry is on a trajectory for significant growth, driven by the increasing importance of accurate blood analysis for optimal patient care. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is expected to reach a substantial US$2,170.8 million by 2032. This translates to a promising Compound Annual Growth Rate (CAGR) of 6.3% over the next decade. Notably, the market is already demonstrating impressive growth, with a projected valuation of US$1,178.4 million by the end of 2022.

Platelets, integral to the human body’s clotting process, play a critical role in preventing excessive bleeding when damage occurs. They travel to the affected area, transforming into a mesh that adheres to the damaged surface. Maintaining an appropriate number of functional platelets is paramount for this process. However, in certain cases, platelets lose their ability to bind to damaged sites, compromising their ability to control bleeding.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1727

Global Platelet Function Test Industry: Drivers and Restraints

With the increasing number of platelet disorders, the demand for platelet function tests is increasing rapidly. The increasing incidence rate of disorders like thrombocythemia (abnormal increase in the number of platelets) and thrombocytopenia (decrease in the number of platelets) is expected to boost the demand for the platelet function test industry during the forecast period.

It has been observed that platelet function disorders are 1.5 times more likely to occur in women and the geriatric population, with the increasing global life expectancy rate there is an expansion in the patient pool requiring platelet function tests, which in turn is expected to drive demand for the platelet function test industry. Increasing adoption of platelet therapy for cancer patients is also expected to boost the platelet function test industry due to the increasing number of cancer patients. Some other factors like an increasing number of surgical procedures, increasing awareness, and the development of new technology are expected to boost the platelet function test industry.

However, the reduction in the reimbursement rates for the tests and the dearth of trained professionals in emerging economies are expected to decelerate the market growth.

Platelet Function Test Industry: Overview and Region-wise Outlook

Geographically, the platelet function test market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA).

North America and Western Europe are expected to lead the platelet function test market during the forecast period, mainly due to the high adoption rate of platelet function tests and high awareness of platelet-related disorders. Also, the presence of several manufacturers and an increasing rate of clinical research are expected to promote platelet function test market growth in this region.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-1727

APEJ region is expected to witness high market growth followed by North America and Western Europe mainly due to the large patient population and the development of affordable platelet function tests by the manufacturers owing to low taxation rates. The improving distribution channel and large patient pool in this region are also expected to boost the platelet function test market. Eastern Europe, Japan, and Latin America are expected to follow next due to increasing government spending on the healthcare and development of efficient reforms for manufacturers of platelet function test kits and systems.

MEA is also expected to witness significant growth in the Global Platelet Function Test Industry owing to improving political stability and increasing awareness related to platelet disorders.

Global Platelet Function Test Industry: Key Players

Some key participants in the Global Platelet Function Test Industry are F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Siemens AG, Accriva Diagnostics, Helena Laboratories, Terumo BCT, Inc., Fresenius SE & Co KGaA., and Aggredyne, Inc.

Currently, companies are focusing on developing more accurate test systems and analyzers along with a constant effort to establish distribution channels in emerging countries.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology, and applications.

The report covers an exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition and companies involved
  • Technology
  • Value Chain

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1727

Global Platelet Function Test Industry: Segmentation

by product

  • Systems
  • Reagents
  • Accessories

by end-user

  • Hospitals
  • Blood banks
  • Diagnostics centers
  • Academic institutions
  • Others

by application

  • Clinical applications
  • Research applications
  • Pharmaceutical development
  • Others

 About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Peripheral Vascular Devices Industry Primed for Growth at 6.6% CAGR, Reaching US$8.9 Billion by 2032 | FMI Study

Global Peripheral Vascular Devices Industry
Global Peripheral Vascular Devices Industry

The Global Peripheral Vascular Devices Industry is poised for a remarkable expansion, driven by the increasing need for treatment of peripheral artery disease (PAD) and other vascular ailments. According to a recent analysis by Future Market Insights (FMI), a leading market research firm, the market is projected to reach a value of US$8.9 billion by 2032. This translates to a steady Compound Annual Growth Rate (CAGR) of 6.6%, signifying a significant rise in demand for these specialized medical devices.

Peripheral Vascular Stents Lead the Way

The dominance of peripheral vascular stents in 2021 serves as a prime example of this growth. These devices, capturing a remarkable 78.5% global market share according to FMI’s research, underscore the industry’s growing focus on innovative solutions for treating peripheral vascular diseases.

FMI’s latest business report is a beacon of insight, providing a detailed exploration of the historical and current panorama of the global Peripheral Vascular Devices industry. The report encapsulates crucial aspects such as production, consumption, volume, and value, offering invaluable insights. It meticulously dissects the market into various segments, regions, and key players, all while considering demand patterns and growth prospects.

Request a Sample of this Report Using a Work Email to Get a Quick Reply!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15695

The significant growth of the Global Peripheral Vascular Devices Industry underscores the increasing demand for innovative medical solutions, highlighting the industry’s potential for substantial expansion in the coming years. As the market continues to evolve, FMI remains dedicated to delivering comprehensive market intelligence and analysis to support industry stakeholders in making informed decisions.

Crucial information and forecast statistics covered in the Peripheral Vascular Devices industry report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Global Peripheral Vascular Devices Industry: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Peripheral Vascular Devices industry. Competitive information detailed in the Peripheral Vascular Devices market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Peripheral Vascular Devices industry report.

Access Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-15695

 Key players covered in the report include:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation (Endovastec™)
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • Others

Important Questions Answered in the Global Peripheral Vascular Devices Industry Report

  • Which end-user remains the top revenue contributor in different regional markets?
  • At what rate has the Global Peripheral Vascular Devices Industry been expanding during the forecast period?
  • How will the global Peripheral Vascular Devices industry look like by the end of the forecast period?
  • What innovative strategies are adopted by Peripheral Vascular Devices market players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Peripheral Vascular Devices industry?

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis of growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment of the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis of each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with the necessary information to make critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Peripheral Vascular Devices industry

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/15695

Global Peripheral Vascular Devices Industry: Segmentation

By Product:

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery:

  • Carotid Artery
  • Fem-Pop Artery
  • lilac Artery
  • Infrapop Artery

By End User:

 Author

Sabyasachi Ghosh (Associate Vice President at Future Industry Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Industry Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Industry Insights (FMI)

Future Industry Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the Industry. FMI stands as the leading global provider of Industry intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals Industries. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Industry Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futureIndustryinsights.com
Website: https://www.futureIndustryinsights.com
LinkedIn| Twitter| Blogs | YouTube